Ilevro (nepafenac) is an FDA-approved ophthalmic medication used to treat inflammation and reduce pain following cataract surgery. This article will explore Ilevro's uses, dosage, demographic, side effects, interactions, and generic options. Uses After cataract surgery, inflammation can lead to discomfort and potential complications. Ilevro is an ophthalmic nonsteroidal anti-inflammatory drug (NSAID) indicated to reduce pain and inflammation post-surgery. This medication may work by inhibiting the production of prostaglandins, which contribute to inflammation. Dosage The standard dosage for Ilevro is one drop in the affected eye(s) once daily for a duration of 14 days. It is recommended that patients wait at least 5 minutes before instilling other ophthalmic medications and that they thoroughly wash their hands before administering the medication. Demographic Ilevro is indicated for use in adults only. It is not recommended for use in children or anyone under 18 years of age. Additionally, patients with a history of hypersensitivity to NSAIDs or who have experienced asthma, urticaria, or other allergic-type reactions after taking aspirin or other NSAIDs should avoid using Ilevro. Side Effects Like any medication, Ilevro can cause side effects. Common adverse reactions include reduced visual acuity, eye irritation, and increased intraocular pressure. In some cases, the drug may cause eye pain, foreign body sensation, or corneal edema. If any unusual side effects or reactions are experienced, patients should seek medical attention immediately. Interactions Ilevro has the potential to interact with other medications, including other ophthalmic NSAIDs, corticosteroids, or antiplatelet medications such as aspirin. Patients should inform their physician of all drugs they are taking, including over-the-counter and prescription medications, as well as any vitamins or herbal supplements. Generic Options Generic versions of Ilevro are not currently available in the United States. However, nepafenac is available in other brand-name formulations, such as Nivexol and Nevanac. In conclusion, Ilevro is an effective medication for reducing inflammation and pain post-cataract surgery. Patients should follow recommended dosing instructions, be aware of potential side effects and interactions, and notify their physicians of all medications being taken.